4.8 Article

High Dimensional Imaging Mass Cytometry Panel to Visualize the Tumor Immune Microenvironment Contexture

Journal

FRONTIERS IN IMMUNOLOGY
Volume 12, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2021.666233

Keywords

imaging mass cytometry; tumor immune microenvironment; biomarkers; immune therapies; panel design

Categories

Funding

  1. Centre National de la Recherche Scientifique
  2. Institut national de la sante et de la recherche medicale
  3. Universite Cote d'Azur
  4. Canceropole PACA
  5. Region Provence-Alpes-Cote d'Azur
  6. Fondation d'entreprise SILAB Jean PAUFIQUE
  7. Fondation d'Entreprise Bristol-Myers Squibb pour la Recherche en Immuno-Oncologie
  8. Fondation ARC pour la recherche sur le Cancer
  9. Ligue Nationale contre le Cancer
  10. Fondation de l'Avenir
  11. French Government (National Research Agency, ANR) through the Investments for the Future program LABEX SIGNALIFE [ANR-11-LABX-0028]
  12. French Government (National Research Agency, ANR) through the Investments for the Future program IDEX UCAJedi [ANR-15-IDEX-01]

Ask authors/readers for more resources

The IMC panel with 39 antibodies designed for staining human tumor sections provides a powerful tool for studying tumor immune microenvironment, revealing interactions between immune cells and structural components such as tumor cells.
The integrative analysis of tumor immune microenvironment (TiME) components, their interactions and their microanatomical distribution is mandatory to better understand tumor progression. Imaging Mass Cytometry (IMC) is a high dimensional tissue imaging system which allows the comprehensive and multiparametric in situ exploration of tumor microenvironments at a single cell level. We describe here the design of a 39-antibody IMC panel for the staining of formalin-fixed paraffin-embedded human tumor sections. We also provide an optimized staining procedure and details of the experimental workflow. This panel deciphers the nature of immune cells, their functions and their interactions with tumor cells and cancer-associated fibroblasts as well as with other TiME structural components known to be associated with tumor progression like nerve fibers and tumor extracellular matrix proteins. This panel represents a valuable innovative and powerful tool for fundamental and clinical studies that could be used for the identification of prognostic biomarkers and mechanisms of resistance to current immunotherapies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available